このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Park Prescription Trial

2017年6月27日 更新者:Dr Falk Mueller-Riemenschneider、National University of Singapore
The purpose of this study is to test the effectiveness of prescribing park use (i.e., ''Park Prescription'') to insufficiently active individuals. It is hypothesized that Park Prescription will motivate the target population to increase physical activity and thereby improve their physical and mental health.

調査の概要

状態

完了

条件

詳細な説明

BACKGROUND: There are substantial international research findings supporting the role that natural environments play in enhancing human health and the prevention of chronic diseases. Also, there is evidence highlighting the (cost-) effectiveness of prescribing physical activity to promote one's physical activity and health. However, there is a lack of methodologically rigorous studies that have looked into the effectiveness of combining these two promising approaches; i.e., physical activity prescription with a focus on the use of parks and green spaces: Park Prescription.

AIMS: This Randomized Controlled Trial (RCT) will investigate the concept of Park Prescription as a health promoting intervention for individuals. The primary objective is to investigate the effectiveness of a park prescription interventions to increase participant's time spent in moderate to vigorous physical activity (MVPA). Main secondary objectives are to assess; A) improvement in physical health (e.g., blood sugar and blood pressure) and health behaviour (e.g., sitting time); B) improvement in mental health (e.g., quality of life); 3) intervention implementation fidelity and the association with park use and perceived study participant satisfaction.

METHODOLOGY: Participants aged between 40 and 65 years will be recruited from the Singapore Population Health Community Screening Programme conducted by Alexandra Health Pte Ltd. They will be randomly assigned to one of the following two arms; 1) park prescription + participation in a weekly structured physical activity program conducted in the park, and 2) control group. Participants will be enrolled in the study for a period of 6 months. They will have to complete a baseline assessment, 3-month and 6-month follow-up. The investigators aim to recruit 80 participants in each arm, making a total of 160 study participants.

研究の種類

介入

入学 (実際)

160

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

40年~65年 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

Subjects must meet all of the inclusion criteria as listed below to participate in the study.

Study participants must:

  1. be not currently sufficiently active (less than 150 minutes per week of exercise);
  2. complete and pass the PAR-Q+*;
  3. have a blood pressure of less or equal to (<=) 139 mmHG (systolic) over less or equal to (<=) 89 mmHG (diastolic);
  4. have fasting glucose levels of less or equal to (<=) 6.0 mmol/l);
  5. be Singaporean or Permanent Residents;
  6. be able to write and read;
  7. provide informed consent.

Exclusion Criteria:

All subjects meeting any of the following exclusion criteria will be excluded from participation:

  1. pregnant women;
  2. people who have severe medical conditions prohibiting participation in physical activity as assessed by the PAR-Q (including, heart disease, lung disease, diabetes);
  3. people who have a blood pressure of >139 mmHG (systolic) over >89 mmHG (diastolic);
  4. people who have fasting glucose levels of >6.0 mmol/l);
  5. those with physical disabilities or lower limb disorders.

    • The Physical Activity Readiness Questionnaire (PAR-Q) is a self-guided, nine question screening tool that can quickly identify conditions or risk factors that require further assessment before engaging in physical activity. See: British Columbia Ministry of Health Department of National Health and Welfare: Physical Activity Readiness Questionnaire. Canada: 1992.For the current study, we are using an amended version of the PAR-Q.

The PAR-Q+ also includes an additional section to formally assess subjects' age, whether they have physical disabilities or lower limb disorders, and their physical activity status.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Park prescription
The participants in this group will receive a brief counseling on physical activity together with a park prescription that highlights the importance of engaging in at least 150 minutes of physical activity per week and the possibility of engaging in physical activity in the park. In addition, they are invited to join in a structured and supervised physical activity program in the park. The structured physical activity program will take place in public parks located in the participants' neighbourhood. Participants will receive text messages for reminder and registration purposes approximately once a week. Also, participants will receive a sheet to monitor their weekly physical activity, information about parks in their neighborhood, and a counseling phone call half-way through the study.
Please refer to the information included in the arm description.
介入なし:Control
The participants in this group will not be given any park prescription or be invited to participate in the weekly program in the park. However, they will receive all the information materials provided to the experimental group after the study has ended.

この研究は何を測定していますか?

主要な結果の測定

結果測定
時間枠
Hours/week spent in Moderate to Vigorous Physical Activity (MVPA) assessed objectively with accelerometry
時間枠:At 6 months follow-up
At 6 months follow-up

二次結果の測定

結果測定
時間枠
Fasting glucose levels (mmol/l)
時間枠:At 6 months follow-up
At 6 months follow-up
Total cholesterol (mmol/l)
時間枠:At 6 months follow-up
At 6 months follow-up
LDL (mmol/l)
時間枠:At 6 months follow-up
At 6 months follow-up
HDL (mmol/l)
時間枠:At 6 months follow-up
At 6 months follow-up
Triglycerides (mmol/l)
時間枠:At 6 months follow-up
At 6 months follow-up
Blood pressure (mmHG)
時間枠:At 6 months follow-up
At 6 months follow-up
Body Mass Index (kg/m^2)
時間枠:At 6 months follow-up
At 6 months follow-up
Waist circumference (cm)
時間枠:At 6 months follow-up
At 6 months follow-up
Hours/week spent in Moderate to Vigorous Physical Activity (MVPA) assessed by self-report
時間枠:At 6 months follow-up
At 6 months follow-up
Hours/week spent in sedentary behaviour assessed by self-report
時間枠:At 6 months follow-up
At 6 months follow-up
Psychological distress assessed with Kessler-10
時間枠:At 6 months follow-up
At 6 months follow-up
Physical and mental health functioning assessed with SF-12
時間枠:At 6 months follow-up
At 6 months follow-up

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Falk Mueller-Riemenschneider, Assist Prof、Saw Swee Hock School of Public Health, National University of Singapore

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2016年1月1日

一次修了 (実際)

2017年6月1日

研究の完了 (実際)

2017年6月1日

試験登録日

最初に提出

2015年11月23日

QC基準を満たした最初の提出物

2015年11月24日

最初の投稿 (見積もり)

2015年11月26日

学習記録の更新

投稿された最後の更新 (実際)

2017年6月29日

QC基準を満たした最後の更新が送信されました

2017年6月27日

最終確認日

2017年6月1日

詳しくは

本研究に関する用語

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する